Journals / MN Kardiyoloji / 2005 / Cilt: 12 - Sayı: 5

Macro creatine kinase: Report of three cases and a review of the current literature

Makro kreatin kinaz: Üç olgu sunumu ve güncel literatürden bir derleme

Pages
355–359
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Keeping macro creatine ki­nase in mind while evaluating the laboratory results will keep a special subset of patients away from unnecessary in­vasive diagnostic procedures.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:MB isoform of creatine kinase (CK-MB) is a frequently used biochemical marker for detecting myocardial injury.
📊
Key Findings & Data:But the­re are also instances in which CK-MB can not be used for diagnostic purposes.
💡
Conclusion & Impact:Keeping macro creatine ki­nase in mind while evaluating the laboratory results will keep a special subset of patients away from unnecessary in­vasive diagnostic procedures.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Miyokard enfarktüsü · Kreatin kinaz · MB form

Abstract

MB isoform of creatine kinase (CK-MB) is a frequently used biochemical marker for detecting myocardial injury. But the­re are also instances in which CK-MB can not be used for diagnostic purposes. The three cases we presented in this paper had high levels of CK-MB but other biochemical markers of myocardial injury were not revealing any myo­cardial necrosis suggesting false positive CK-MB elevation. In all cases macro creatine kinase was detected which is a frequent cause of false positive CK-MB. In this report while presenting three cases with macro creatine ki­nase we discussed the biochemical properties and clinical importance of this molecule. Keeping macro creatine ki­nase in mind while evaluating the laboratory results will keep a special subset of patients away from unnecessary in­vasive diagnostic procedures.

Özet

Kreatin kinaz enziminin MB izoformu (CK-MB) miyokard infarktüsü tanısı için sıkça kullanılan bir biyokimyasal be­lir­teç­tir. Ancak CK-MB’nin tanısal değerinin olmadığı bazı durumlar da söz konusudur. Sunduğumuz üç olguda CK-MB değerleri yüksek olup kardiyak miyosit nekrozunun diğer biyokimyasal belirteçlerinde herhangi bir yükselme göz­lenmemiştir. Her üç olguda da yalancı CK-MB yüksekliğinin sık sebeplerinden biri olan makro kreatin kinaz sap­tan­mıştır. Bu yazımızda makro kreatin kinazla ilgili üç olgudan ve söz konusu molekülün biyokimyasal ö­zel­lik­le­rin­den söz ettik. CK-MB sonucunu değerlendirirken makro kreatin kinaz konusunun akılda tutulması, belirli bir hasta gru­bunu tanı koyma sürecinde gereksiz invaziv prosedürlerden koruyacağı gibi tanısal belirsizliğin olduğu has­ta­lar­da klinik bulguların ve alternatif tetkiklerin önemini hatırlatacaktır.

🔖

Cite This Article

ÇELİK, T., YÜKSEL, U. Ç., KURŞAKLIOĞLU, H., İYİSOY, A., YAMAN, H., IŞIK, E. (2005). Macro creatine kinase: Report of three cases and a review of the current literature. MN Kardiyoloji, Cilt: 12 - Sayı: 5, 355–359. https://ajindex.com/articles/297995

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Galasso PJ, Litin ŞC, O'Brien JF. The macroenzymes: a clinical review. Mayo Clin Proc 1993; 68:349-54
  2. Briani C, Zaninotto M, Forni M, Burra P. Macroenzymes: toc often overlooked. Journal of Hepatology 2003; 38:119
  3. Wilding P, Cooke WT, Nicholson GT. Globulin bounc amylase: a cause of persistently elevated levels in serum. Ann Intern Med 1964; 60:1053-9
  4. Remaley AT, Wilding P. Macroenzymes: biochemica characterization, clinical significance and laboratory detection Clin Chem 1989; 35:2261-70
  5. Thomas L. Labor und diagnose. TH Book: Verlagsgesellscahft mbH, Frankfurt/Main 2000:1583
  6. Klonoff DC. Macroamylasemia and other immunglobulincomplexed enzyme disorders. West J Med 1980; 133:392-407
  7. Turecky L. Macroenzymes and their clinical significance Bratisl Lek Listy 2004; 105:260-3
  8. Durr HK, Bode C, Krupinski R, Bode JC. A comparisoi between naturally occuring macroamylasemia am macroamylasemia induced by hydroxyethyl starch. Europ J Clii Invest 1978; 8:189-91
  9. Moss DW, Henderson AR. Clinical enzymology. In: Bruti: CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry. 3n ed. Philadelphia: W.B. Saunders Co 1999:657-67
  10. B. Galarraga, D. Sinclair, M.N. Fahie-Wilson et al. A rare bu important cause for a raised serum creatine kinasi concentration: two case reports and a literature reviev Rheumatology 2003; 42:186-8
  11. Rosa-Jimenez F, Gasso de Campos M, Camacho Reina Mv et al. Macro creatine kinase type 1 as a cause of increase of CK-MB isoenzyme. Apropos of 7 cases. Rev Esp Cardiol 1997 50:166-72
  12. Sturk A, Sanders GT. Macro enzymes: prevalence composition, detection and clinical relevance. J Clin Chem Clii Biochem 1990; 28:65-81
  13. Lee KN, Csako G, Bernhardt P, Elin RJ. Relevance of macr creatine kinase type 1 and type 2 isoenzymes to laboratory an clinical data. Clin Chem 1994; 40:1278-83
  14. Wu AHB, Herson VC, Bowers GN Jr. Macro creatine kinas 1 and 2: Clinical significance in neonates and children a compared with adults. Clin Chem 1983; 29:201-4
  15. Whelan PV, Malkus H. A macro CK isoenzyme in serum c apparently healthy individuals. Clin Chem 1983; 29:1411-4
  16. Stein W, Bohner J, Renn W, Maulbetsch R. Macro creatin kinase type 2: results of a prospective study in hospitalize patients. Clin Chem 1985; 31:1959-64
  17. Wu AHB, Herson VC, Bowers GN Jr. Macro creatine kinas 1 and 2: Clinical significance in neonates and children a compared with adults. Clin Chem 1983; 29:201-4
  18. Mercer DW, Talamo TS. Multiple markers